It could also be conceivable that uromodulin, besides its potential as an oncogenic biomarker, could be useful in perioperative diagnostics to estimate fibrotic and atrophic renal damage due to tumour growth with associated early-stage chronic kidney disease [46,47]. The gene discussed is UMOD; the disease is neoplasm.